Anti-ANNEXIN V (cas 136107-94-3) antibodies: are they prothrombotic?

Add time:09/04/2019    Source:sciencedirect.com

Annexin V inhibits prothrombin activation and is able to prevent thrombus formation under normal venous and arterial blood flow conditions. Antibodies to annexin V have been identified in association with several pathological conditions, including systemic lupus erythematosus (SLE) with or without anti-phospholipid syndrome, recurrent spontaneous abortions and systemic sclerosis (SSc). These antibodies are suspected to exert a detrimental role and interfere with annexin V function. Thus, they have been associated with the occurrence of foetal loss and venous and/or arterial thrombosis in SLE patients, as well as digital ischemia in SSc patients. However, their true pathogenic role remains to be proven.

We also recommend Trading Suppliers and Manufacturers of ANNEXIN V (cas 136107-94-3). Pls Click Website Link as below: cas 136107-94-3 suppliers

Prev:Combination of copeptin, placental growth factor and total ANNEXIN V (cas 136107-94-3) microparticles for prediction of preeclampsia at 10–14 weeks of gestation
Next:Discrimination between primary necrosis and apoptosis by necrostatin-1 in ANNEXIN V (cas 136107-94-3)-positive/propidium iodide-negative cells)